Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by carcarneedon Apr 20, 2011 9:22pm

200 Views

Post# 18465844

RE: Good luck to myself.

First Quarter Results said " the decline was primarily due to the timing of customer orders and, in particular, a one-time unplanned production adjustment by one large customer. This long-term relationship will be returning to a regular delivery schedule during the next 9 months. " So Good luck to myself.

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023